(4-traders.com) Volcano Corp. said it has signed an agreement to acquire AtheroMed, a privately-held company that has developed the Phoenix Atherectomy System used in the treatment of peripheral artery disease (PAD). According to a company release on May 27, the Phoenix, which received 510(k) clearance in January 2014 and has a CE Mark, enables physicians to...http://www.4-traders.com/VOLCANO-CORPORATION-17313/news/Volcano--Inks-Agreement-to-Buy-AtheroMed-18525799/